[VSsupport]

<img alt="" height="1" width="1" />Albireo reports positive results from phase 1b study of A3309 for chronic ...Therapeutics Daily (press release) (registration)... a first in class compound developed for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome (IBS-C). ...<nobr>and more »</nobr>

View the full article